SV40-like sequences in human bone tumors

Oncogene

Volumn 13, Issue 3, 1996, Pages 527-535

  Carbone, Michele ^a,b   Rizzo, Paola ^a,b   Procopio, Antonio ^c   Giuliano, Mariateresa ^c   Pass, Harvey I ^d   Gebhardt, Mark C ^e   Mangham, Charles ^e   Hansen, Marc ^f   Malkin, David F ^g   Bushart, Gregory ^h   Pompetti, Franca ⁱ   Picci, Piero ⁱ   Levine, Arthur S ^b   Bergsagel, John D ^j   Garcea, Robert L ^k  

^a UNIVERSITY OF CHICAGO   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF CHIETI   (Italy)

^d NATIONAL CANCER INSTITUTE   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f BOSTON UNIVERSITY   (United States)

^g HOSPITAL FOR SICK CHILDREN   (Canada)

^h UNIVERSITY OF ULM   (Germany)

ⁱ RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^j Scottish Rite Hospital   (United States)

^k CHILDREN S HOSPITAL   (United States)

more..

Author keywords

Human bone tumors; SV40

Indexed keywords

CAPSID PROTEIN; DNA; RETINOBLASTOMA PROTEIN; VIRUS DNA; VIRUS LARGE T ANTIGEN;

ARTICLE; BINDING SITE; BONE TUMOR; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA SEQUENCE; HUMAN; HUMAN TISSUE; INTRON; MAJOR CLINICAL STUDY; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIMIAN VIRUS 40; SOUTHERN BLOTTING;

BASE SEQUENCE; BONE NEOPLASMS; DNA, NEOPLASM; DNA, VIRAL; GENOME, VIRAL; HUMANS; MOLECULAR SEQUENCE DATA; SIMIAN VIRUS 40;

CRICETINAE; DNA VIRUSES; MIRIDAE; MONKEY VIRUS; SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40;

EID: 9444281412     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Abramczuk J, Pan S, Maul G and Knowles BB. (1984). J. Virol., 49, 540 - 548.
2. Avantaggiati ML, Carbone M, Graessmann A, Howard B and Levine AS. EMBO J., In press.
3. Bergsagel DJ, Finegold MJ, Butel JS, Kupsky WJ and Garcea R. (1992). N. Engl. J. Med., 36, 988 - 993.
4. Bright K, Shearer MH and Kennedy RC. (1994). J. Immunol., 153, 2064 - 2072.
5. Brinster RL, Chen HI, Messing A, van Dyke T, Levine AJ and Palmiter RD. (1984). Cell, 37, 367 - 379.
6. Buchman AR, Burnett L and Berg P. (1981). DNA Tumor Viruses, part 2, revised. Tooze J. (ed)., Cold Spring Harbor Press, New York. pp. 799 - 841.
7. Butel JS. (1994). Encyclopedia of Virology, Vol. 2, Webster, RG & Granoff A. (eds.), Academic Press, San Diego, pp. 1322 - 1329.
8. Carbone M, Lewis Jr AM, Matthews BJ, Levine AS and Dixon K. (1989). Cancer Res., 49, 1565 - 1571.
9. Carbone M, Pompetti F, Cicala C, Nguyen P, Dixon K and Levine AS. (1991). Molecular Basis of Human Cancer, C. Nicolini (ed.) Plenum Press, New York-London, pp. 191 - 206.
10. Carbone M, Pass HI, Rizzo P, Marinetti MR, Di Muzio M,. Mew DJY, Levine AS and Procopio A. (1994). Oncogene, 9, 1781 - 1790.
11. Carbone M., Rizzo P and Pass HI. (1995). In: DNA Tumor Viruses: Oncogenic Mechanisms. Barbanti Brodano G, Bendinelli M & Friedman H. (eds), Plenum Press, New York & London, pp. 75 - 90
12. Cicala C, Pompetti F, Nguyen P, Dixon K, Levine AS and Carbone M. (1992). Virology, 190, 475 - 479.
13. Cicala C, Pompetti F and Carbone M. (1993). Am. J. Pathol., 142, 1524 - 1533.
14. Claudio PP, Howard CM, Baldi A, De Luca A, Fu Y, Condorelli G, Sun Y, Colburn N, Calabretta B and Giordano A. (1994). Cancer Res., 54, 5556 - 5560.
15. Cristaudo A, Vivaldi A, Sensales G, Guglielmi G, Ciancia E, Elisei R and Ottenga F. (1995). J. Exp. Pathol. Toxicol. Oncol., 14, 29 - 34.
16. De Mattel M, Martini F, Corallini A, Gerosa M, Scotland K., Carinci P, Barbanti-Brodano G and Tognon M. (1995). Int. J. Cancer, 61, 756 - 760.
17. Diamandopoulous GT. (1972). Science, 176, 173 - 175.
18. Dixon K, Ryder BJ and Burch-Jaffe E. (1982). Nature, 296, 672 - 675.
19. Fanning E and Knippers R. (1992). Annu. Rev. Biochem., 61, 55 - 85.
20. Frost JA, Alberts AS, Sontag E, Guan K, Mumby MC and Feramisco JR. (1994). Mol. Cell. Biol., 14, 6244 - 6252.
21. Geissler E and Theile M. (1983). Human Genet., 63, 1 - 12.
22. Geissler E. (1990). Prog. Med. Virol, 37, 211 - 222.
23. Gerber P and Kirschstein RL. (1962). Virology, 18, 582 - 588.
24. Ilyinskii PO, Daniel MD, Horvath CJ and Desrosiers RC. (1992). J. Virol., 66, 6353 - 6360.
25. Jensen F, Koprowski H, Pagano JS, Ponten J and Ravdin RG. (1964). J. Natl. Cancer Inst., 29, 1123 - 1145.
26. Ke Y, Reddel RR, Gerwin BI, Reddel HK, Somers ANA, McMenamin MG, La Veck MA, Stahel RA, Lechner JF and Harris CC. (1989). Am. J. Pathol., 134, 979 - 991.
27. Koprowski H, Ponten JA, Jensen F, Ravdin RG, Moorhead P and Saksela E. (1962). J. Cell. Comp. Physiol, 59, 281 - 292.
28. Krieg P, Amtmann E, Jonas D, Fisher H, Zang K and Sauer G. (1981). Proc. Natl. Acad. Sci. USA, 78, 6446 - 6450.
29. Krieg P and Scherer G. (1984). Virology, 138, 336 - 340.
30. Lednicky JA, Garcea RL, Bergsagel DJ and Butel JS. (1995a). Virology, 212, 710 - 717.
31. Lednicky JA, Wong C and Butel JS. (1995b). Virus Res., 35, 143 - 153.
32. Lewis Jr AM. (1973). Biohazards in Biological Research. Hellman A. Oxman M.and Pollack R. (eds.), Cold Spring Harbor Lab Press, New York. pp. 96 - 113.
33. Lewis Jr AM and Martin RG. (1979). Proc. Natl. Acad. Sci., 76, 4299 - 4302.
34. Martini F, De Mattei M, Iaccheri L, Lazzarini L, Barbanti-Brodano G, Tognon M and Gerosa M. (1995). J. Natl. Cancer Inst., 87, 1331.
35. Martin JD and Li P. (1991). Virus Res., 19, 163 - 172.
36. Mayol X, Grana X, Baldi A, Sang N, Hu Q and Giordano A. (1993). Oncogene, 8, 2561 - 2566.
37. Melnick JL and Stinebaugh S. (1962). Proc. Soc. Exp. Biol. Med., 109, 965 - 968.
38. Morris JA, Johnson KM, Aulisio GC, Chanock RM and Knight V. (1961). Proc. Soc. Exp. Biol. Med., 108, 56 - 59.
39. Pass HI, Kennedy R and Carbone M. Important Advances in Oncology, De Vita Jr VT, Hellman S and Rosenberg SA (eds.) Lippincot Press, In press.
40. Pass HI, Mew DJY, Carbone M, Matthews WA, Donington J, Baserga R, Walker C, Resnicoff M and Steinberg S. Cancer Res., In press.
41. Pompetti F, Rizzo P, Simon RM, Freidlin B, Mew DJY, Pass HI, Picci P, Levine AS and Carbone M. J. Cell. Biochem., In press.
42. Porcu P, Ferber A, Pietrzkowski Z, Roberts CT, Adamo M, LeRoith D and Baserga R. (1992). Mol. Cell. Biol., 12, 5069 - 5077.
43. Rabson AS. (1962). J. Natl. Cancer Inst., 29, 1123 - 1145.
44. Ray FA. (1995). In: DNA Tumor Viruses: Oncogenic Mechanisms, Barbanti Brodano G, Bendinelli M and Friedman H. (eds.), Plenum Press, New York & London, pp. 15 - 26.
45. Reddel RR, Malan-Shibley L, Gerwin BI, Metcalf RA and Harris CC. (1989). J. Natl. Cancer Inst., 81, 945 - 948.
46. Sambrook S, Fritsch EF and Maniatis T. (1989). In Molecular Cloning Vol. 2, 2nd ed. Cold Spring Harbor, N.Y., Cold Spring Harbor Laboratories, pp. 9.32 - 9.58.
47. Shah KV and Nathanson N. (1976). Am. J. Epidemiol., 103, 1 - 12.
48. Shein HM and Enders JF. (1962). Proc. Natl. Acad. Sci. USA, 48, 1164 - 1172.
49. Simmons DT. (1995). In: DNA Tumor Viruses: Oncogenic Mechanisms, Barbanti Brodano G, Bendinelli M and Friedman H. (eds.), Plenum Press, New York and London, pp. 27 - 50.
50. Soriano F, Shelburne CE and Gokcen M. (1974). Nature, 249, 421 - 424.
51. Stewart N and Bacchetti S. (1991). Virology, 190, 49 - 57.
52. Tiemann F and Deppert W. (1994). Oncogene, 9, 1907 - 1915.
53. Todaro GJ and Martin GM. (1967). Proc. Soc. Exp. Biol. Med., 124, 1232 - 1237.
54. Valentinis B, Porcu P, Quinn K and Baserga R. (1994). Oncogene, 9, 825-831.
55. Walker DL and Frisque RJ. (1986). In: The papovaviridiae. Vol 1: The polyomaviruses, Salzman NP (ed). Plenum Press, New York-London, pp. 327-377.
56. Walsh JW, Zimmer SG and Perdue ML. (1982). Neurosurgery, 10, 643 - 662.
57. Wang R and Bautch VL. (1991). J. Virol., 65, 5174-5183.
58. Weiner LP, Herndon RM, Narayan O, Johnson RT, Shah K, Rubinestein LJ, Preziosi TJ and Conley FK. (1972). N. Engl. J. Med., 305, 1517 - 1518.
59. Wilkie TM, Schmidt RA, Baetscher M and Messing A. (1994). Oncogene, 9, 2889 - 2895.
60. Yoshiike K and Takemoto KK. (1986). In The papovaviridiae. Vol 1: The polyomaviruses, Salzman NP (ed). Plenum Press, New York-London, pp. 295 - 326.